S103: TRIAL IN PROGRESS: A PHASE 2, OPEN-LABEL STUDY EVALUATING THE SAFETY AND EFFICACY OF THE PKR ACTIVATOR ETAVOPIVAT (FT-4202) IN PATIENTS WITH THALASSEMIA OR SICKLE CELL DISEASE.

2022

https://researcherprofiles.org/profile/425025913

A. Lal, C. Brown, T. Coates, T. Kalfa, J.L. Kwiatkowski, J. Brevard, C. Trenor, K. Wood, S. Sheth